Dynavax Technologies (DVAX) Cash from Financing Activities: 2009-2025
Historic Cash from Financing Activities for Dynavax Technologies (DVAX) over the last 15 years, with Sep 2025 value amounting to -$61,000.
- Dynavax Technologies' Cash from Financing Activities fell 102.46% to -$61,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$202.7 million, marking a year-over-year decrease of 14741.58%. This contributed to the annual value of -$102.0 million for FY2024, which is 7460.53% down from last year.
- According to the latest figures from Q3 2025, Dynavax Technologies' Cash from Financing Activities is -$61,000, which was up 99.92% from -$71.9 million recorded in Q2 2025.
- In the past 5 years, Dynavax Technologies' Cash from Financing Activities ranged from a high of $32.3 million in Q1 2021 and a low of -$98.9 million during Q4 2024.
- For the 3-year period, Dynavax Technologies' Cash from Financing Activities averaged around -$18.6 million, with its median value being -$1.4 million (2024).
- As far as peak fluctuations go, Dynavax Technologies' Cash from Financing Activities skyrocketed by 22,348.48% in 2021, and later plummeted by 5,667.29% in 2024.
- Dynavax Technologies' Cash from Financing Activities (Quarterly) stood at $14.8 million in 2021, then tumbled by 98.97% to $153,000 in 2022, then skyrocketed by 1,060.78% to $1.8 million in 2023, then tumbled by 5,667.29% to -$98.9 million in 2024, then plummeted by 102.46% to -$61,000 in 2025.
- Its last three reported values are -$61,000 in Q3 2025, -$71.9 million for Q2 2025, and -$31.9 million during Q1 2025.